BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 34319023)

  • 1. Monitoring Of High-Dose Methotrexate (Mtx)-Related Toxicity and Mtx Levels in Children with Acute Lymphoblastic Leukemia: A Pilot-Study in Indonesia.
    Sari NM; Rakhmilla LE; Bashari MH; Zazuli Z; Suryawan N; Susanah S; Reniarti L; Raspati H; Supriyadi E; Kaspers GJL; Idjradinata P
    Asian Pac J Cancer Prev; 2021 Jul; 22(7):2025-2031. PubMed ID: 34319023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of the plasma methotrexate concentration during high-dose methotrexate therapy in childhood acute lymphoblastic leukemia.
    Liao C; Nie J; Xu XJ; Zhang JY; Xu WQ; Song H; Shen HP; Shen DY; Zhao FY; Liang J; Miao J; Tang YM
    Leuk Lymphoma; 2024 Jan; 65(1):91-99. PubMed ID: 37820046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Letting Kids Be Kids: A Quality Improvement Project to Deliver Supportive Care at Home After High-Dose Methotrexate in Pediatric Patients With Acute Lymphoblastic Leukemia [Formula: see text].
    Ranney L; Hooke MC; Robbins K
    J Pediatr Oncol Nurs; 2020; 37(3):212-220. PubMed ID: 32102635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic polymorphisms and clinical parameters associated with renal toxicity in Thai hematologic malignancy patients receiving high dose methotrexate.
    Pitakkitnukun P; Pongpitakmetha T; Suttichet TB; Sukkummee W; Chariyavilaskul P; Polprasert C
    Sci Rep; 2024 Apr; 14(1):9695. PubMed ID: 38678107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High dose methotrexate chemotherapy: pharmacokinetics, folate and toxicity in osteosarcoma patients.
    Holmboe L; Andersen AM; Mørkrid L; Slørdal L; Hall KS
    Br J Clin Pharmacol; 2012 Jan; 73(1):106-14. PubMed ID: 21707700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethnic-specific predictors of neurotoxicity among patients with pediatric acute lymphoblastic leukemia after high-dose methotrexate.
    Harris RD; Bernhardt MB; Zobeck MC; Taylor OA; Gramatges MM; Schafer ES; Lupo PJ; Rabin KR; Scheurer ME; Brown AL
    Cancer; 2023 Apr; 129(8):1287-1294. PubMed ID: 36692972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of serum albumin level on high-dose methotrexate induced toxicities in acute lymphoblastic leukemia patients.
    Mirza MA; D Aruna ; Konatam ML
    Int J Health Sci (Qassim); 2023; 17(2):3-9. PubMed ID: 36891042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of gene polymorphisms on delayed MTX clearance, toxicity, and metabolomic changes after HD-MTX treatment in children with acute lymphoblastic leukemia.
    Zhou Y; He H; Ding L; Wang T; Liu X; Zhang M; Zhang A; Fu J
    Eur J Pediatr; 2024 Feb; 183(2):581-590. PubMed ID: 37851084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Adverse effects of high-dose methotrexate therapy].
    Sun Q; Xie Y; Zhao WH; Hua Y; Wu PH; Li S; Lu XT
    Zhongguo Dang Dai Er Ke Za Zhi; 2017 Jul; 19(7):781-785. PubMed ID: 28697831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting delayed methotrexate elimination in pediatric acute lymphoblastic leukemia patients: an innovative web-based machine learning tool developed through a multicenter, retrospective analysis.
    Jian C; Chen S; Wang Z; Zhou Y; Zhang Y; Li Z; Jian J; Wang T; Xiang T; Wang X; Jia Y; Wang H; Gong J
    BMC Med Inform Decis Mak; 2023 Aug; 23(1):148. PubMed ID: 37537590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population Pharmacokinetic Model of Methotrexate in Brazilian Pediatric Patients with Acute Lymphoblastic Leukemia.
    de Oliveira Henz P; Pinhatti AV; Gregianin LJ; Martins M; Curra M; de Araújo BV; Dalla Costa T
    Pharm Res; 2023 Jul; 40(7):1777-1787. PubMed ID: 37291462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A semimechanistic pharmacokinetic/pharmacodynamic model for alanine aminotransferase-based hepatotoxicity of methotrexate in paediatric patients with acute lymphoid leukaemia.
    Yin Q; Cheng Z; Yang M; Wang S; Xie F
    Br J Clin Pharmacol; 2023 Dec; 89(12):3637-3647. PubMed ID: 37548052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Effect of a New Glucose-Methotrexate Conjugate on Acute Lymphoblastic Leukemia and Non-Hodgkin's Lymphoma Cell Lines.
    Woźniak M; Makuch S; Pastuch-Gawołek G; Wiśniewski J; Szeja W; Nowak M; Krawczyk M; Agrawal S
    Molecules; 2021 Apr; 26(9):. PubMed ID: 33925555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carboxypeptidase G2 rescue in patients with methotrexate intoxication and renal failure.
    Buchen S; Ngampolo D; Melton RG; Hasan C; Zoubek A; Henze G; Bode U; Fleischhack G
    Br J Cancer; 2005 Feb; 92(3):480-7. PubMed ID: 15668713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenetic aspects of efficacy and safety of methotrexate treatment in pediatric acute lymphoblastic leukemia.
    Gurieva OD; Savelyeva MI; Valiev TT; Sozaeva ZA; Kondratenko SN; Ilyin MV
    Drug Metab Pers Ther; 2023 Dec; 38(4):349-357. PubMed ID: 38098143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liposomal formulation of a methotrexate lipophilic prodrug: assessment in tumor cells and mouse T-cell leukemic lymphoma.
    Alekseeva AA; Moiseeva EV; Onishchenko NR; Boldyrev IA; Singin AS; Budko AP; Shprakh ZS; Molotkovsky JG; Vodovozova EL
    Int J Nanomedicine; 2017; 12():3735-3749. PubMed ID: 28553111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic drug monitoring of methotrexate in patients with Crohn's disease.
    van de Meeberg MM; Fidder HH; Oldenburg B; Sundaresan J; Struys EA; Montazeri NSM; Mares WGN; Mahmmod N; van Asseldonk DP; Lutgens MWMD; Kuyvenhoven JP; Rietdijk ST; Nissen LHC; Koehestanie P; de Boer NKH; de Jonge R; Bouma G; Bulatović Ćalasan M;
    Aliment Pharmacol Ther; 2023 Dec; 58(11-12):1151-1162. PubMed ID: 37767910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose methotrexate pharmacokinetics and its impact on prognosis of paediatric acute lymphoblastic leukaemia patients: A population pharmacokinetic study.
    Chen X; Li J; Yu L; Hu W; Cai J; Wang Z; Chen C; Zhang X; Xie Y; Wu K; Mo Y; Chen J; Shen S
    Br J Haematol; 2024 Apr; 204(4):1354-1366. PubMed ID: 38432257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of microRNA Polymorphisms with Toxicities Induced by Methotrexate in Children with Acute Lymphoblastic Leukemia.
    Karpa V; Kalinderi K; Fidani L; Tragiannidis A
    Hematol Rep; 2023 Nov; 15(4):634-650. PubMed ID: 37987321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population pharmacokinetics of methotrexate and 7-hydroxymethotrexate and delayed excretion in infants and young children with brain tumors.
    Campagne O; Huang J; Lin T; Reddick WE; Selvo NS; Onar-Thomas A; Ward D; Robinson G; Gajjar A; Stewart CF
    Eur J Pharm Sci; 2024 Feb; 193():106669. PubMed ID: 38070781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.